Risk factors and logistic regression-based nomogram prediction model for diabetic retinopathy in type 2 diabetes mellitus

Introduction Diabetic Retinopathy (DR) is a major cause of irreversible vision loss in Type 2 Diabetes Mellitus (T2DM). Early identification of high-risk patients using readily available clinical tools is crucial. This study aimed to analyze risk factors for DR in T2DM patients and develop a practical nomogram prediction model based on common clinical and laboratory parameters. Methods A retrospective study was conducted on 379 T2DM patients (64 with DR) from a single center. LASSO regression (with the penalty λ chosen by the one-standard-error rule, λ.1se) was used for variable selection; the selected variables were entered into multivariable logistic regression and only those that remained independently significant were retained to construct the nomogram. Model performance was evaluated by discrimination (Area Under the Curve, AUC), calibration (Hosmer-Lemeshow test), and clinical utility (Decision Curve Analysis). Only internal validation (1000-sample bootstrapping) was performed; no external validation cohort was available. Results Five independent risk factors were identified: longer disease duration (OR = 1.27 per year), hypertension (OR = 3.56), elevated fasting plasma glucose (OR = 1.86 per mmol/L), higher glycated hemoglobin (OR = 6.38 per %), and hypertriglyceridemia (triglycerides ≥1.7 mmol/L, OR = 6.37). The nomogram showed good discrimination (AUC 0.922, 95% CI 0.886-0.954; bootstrap optimism-corrected AUC 0.914), good calibration (Hosmer-Lemeshow P = 0.739; bootstrap-corrected calibration slope 0.93), and a positive net benefit on decision curve analysis. Discussion This nomogram, incorporating five easily obtainable clinical variables, is an effective tool for predicting individual DR risk. Its practicality makes it suitable for initial risk stratification in primary care settings, enabling timely ophthalmology referrals. As a single-center model developed with a limited number of DR events and without external validation, its generalizability should be interpreted with caution and confirmed in larger, multi-center, externally validated cohorts.

Authors

Institutions

Publication Details

Journal
Frontiers in Endocrinology
Published
2026-11-16
DOI
https://doi.org/10.3389/fendo.2026.1886207
Primary Topic
Retinal Diseases and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Risk factors and logistic regression-based nomogram prediction model for diabetic retinopathy in type 2 diabetes mellitus

Chuan Tian, Lu Yang, Hong Pan, Li Wang et al.
1 links
Frontiers in Endocrinology
Retinal Diseases and Treatments
article

Risk factors and logistic regression-based nomogram prediction model for diabetic retinopathy in type 2 diabetes mellitus

Chuan Tian, Lu Yang, Hong Pan, Li Wang, Xi Chen
article en

Abstract

Introduction Diabetic Retinopathy (DR) is a major cause of irreversible vision loss in Type 2 Diabetes Mellitus (T2DM). Early identification of high-risk patients using readily available clinical tools is crucial. This study aimed to analyze risk factors for DR in T2DM patients and develop a practical nomogram prediction model based on common clinical and laboratory parameters. Methods A retrospective study was conducted on 379 T2DM patients (64 with DR) from a single center. LASSO regression (with the penalty λ chosen by the one-standard-error rule, λ.1se) was used for variable selection; the selected variables were entered into multivariable logistic regression and only those that remained independently significant were retained to construct the nomogram. Model performance was evaluated by discrimination (Area Under the Curve, AUC), calibration (Hosmer-Lemeshow test), and clinical utility (Decision Curve Analysis). Only internal validation (1000-sample bootstrapping) was performed; no external validation cohort was available. Results Five independent risk factors were identified: longer disease duration (OR = 1.27 per year), hypertension (OR = 3.56), elevated fasting plasma glucose (OR = 1.86 per mmol/L), higher glycated hemoglobin (OR = 6.38 per %), and hypertriglyceridemia (triglycerides ≥1.7 mmol/L, OR = 6.37). The nomogram showed good discrimination (AUC 0.922, 95% CI 0.886-0.954; bootstrap optimism-corrected AUC 0.914), good calibration (Hosmer-Lemeshow P = 0.739; bootstrap-corrected calibration slope 0.93), and a positive net benefit on decision curve analysis. Discussion This nomogram, incorporating five easily obtainable clinical variables, is an effective tool for predicting individual DR risk. Its practicality makes it suitable for initial risk stratification in primary care settings, enabling timely ophthalmology referrals. As a single-center model developed with a limited number of DR events and without external validation, its generalizability should be interpreted with caution and confirmed in larger, multi-center, externally validated cohorts.

Frontiers in EndocrinologyVol. 17
Ningbo University (CN)
Good health and well-being
Retinal Diseases and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon